Enjoy complimentary customisation on priority with our Enterprise License!
According to Technavio's market research report, the global qPCR market will grow at a CAGR of close to 8% during the forecast period. One of the key drivers stimulating the growth of this global market during the next few years will be the increasing demand for new drugs. The number of chronic diseases such as cancer is expected to rise by about 70% over the next two decades due to factors such as the increasing urbanization, sedentary lifestyle, and unbalanced diet. Around 20% of the global cancer deaths and around 70% of global lung cancer deaths are caused by the consumption of tobacco and alcohol. Also, the prevalence of autoimmune disorders such as rheumatoid arthritis, polymyalgia rheumatic, and Crohn's disease is increasing. This will drive the demand for new drugs and clinical researches. Many research applications are carried out using advanced equipment such as quantitative polymerase chain reaction (qPCR). The qPCR analysis technology provides valuable quantitative data analysis of nucleic acids as it is highly specific, sensitive, and accurate. Consequently, demand for qPCR for research as well as testing and diagnostic purposes will increase during the estimated period.
The increasing number of outsourcing activities acts as one of the key trends responsible for the growth in the qPCR market. The outsourcing of research and drug discovery and the development of contract research organization (CROs) by drug manufacturing and biotechnology companies helps vendors to reduce their expenditure on research and developmental activities. This drives the demand for qPCR technologies because CROs highly rely on this technology to develop products and conduct clinical trials.
The qPCR market is highly fragmented due to the presence of many international and regional players in many countries. The increasing number of applications in the field of medical, diagnosis of infectious diseases, and forensics for various purposes will open growth opportunities for these vendors. These players are increasingly adopting mergers and acquisitions to increase their investment in research and developmental activities. Furthermore, vendors are also focusing on offering solutions with features such as consistent quality of data, sensitivity, high-throughput ability, ease of use, multiplexing capacity, and service and support.
Key vendors in this market are -
Other prominent vendors in the market include altona Diagnostics, Cepheid, Roche Diagnostics, Promega, and TATAA Biocenter.
The drug discovery and development segment contributed to the maximum market shares during 2016. This was mainly due to the rising number of pharmaceutical companies and the demand for new drug development. The need for drug discovery and development is increasing due to the outbreak of various unknown diseases in different parts of the world. This has driven the number of pharmaceutical companies on a global level. The segment will continue to account for the largest shares during the predicted period as well since qPCR technology is widely used in various stages of drug discovery such as the study of gene expression, gene profiling, genotyping, and analysis of DNA methylation.
Owing to the presence of developed healthcare infrastructure and many pharmaceutical companies in countries such as the US, the Americas accounted for the majority shares of the qPCR market during 2016. The rise in number of tests related to the development of new drugs and disease diagnosis that requires qPCR techniques and this will turn, fuel the demand for qPCR in this region during the next four years.
Technavio also offers customization on reports based on specific client requirement.
This upcoming industry research report on the global qPCR market offers insights into the key trends and emerging drivers influencing the growth of the lab equipment industry. Our market research reports for this industry follow a comprehensive data collection methodology and offer an analysis of fast growing market segments across the globe.
To correctly determine the lab equipment industry's growth prospects, research analysts at Technavio pursue a mix of primary and secondary market research techniques and consider factors like the market size and the demand for multiple products around the globe. With deep insights on the evolution of consumer behavior and the demand-supply shifts for markets in different locations, our upcoming market research report on the global qPCR market for the forecast period of 2017 to 2021 will help clients comprehend the dynamically changing landscape of the lab equipment industry. In addition, this upcoming report also covers geographies like North America, Europe, ROW, and Asia-Pacific.
This market study offers an extensive analysis of various techniques based on the information gathered from specific resources such as channel partners and market stakeholders. This upcoming report on the global qPCR market also considers the growth of the similar market such as single use bioprocessing system, which is expected to project at a CAGR of above 8% during the period 2017 to 2021. According to our market research analyst, the growing approaches for new diagnostic tools and techniques, evaluation of benefits to patient outcome, and developing genome profiling techniques may influence the global demand for qPCR over the next few years. Furthermore, the upcoming market research report on the global qPCR market also cover vendors such as Cepheid, Qiagen, Affymetrix Inc., Agilent Technologies, Abbott Laboratories, Bio-Rad, Becton, Dickinson and Co., Beckman Coulter Inc., Sigma-Aldrich Corp, GE Healthcare, Life Technologies, and Roche.
The upcoming industry research report on the global qPCR market also identifies the key drivers, emerging trends, coupled with challenges currently experienced by the health and wellness sector. It also furnishes insights into the constantly changing competitive scenario to give clients a complete view of the new research areas industry.
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.